Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenol Addition to Laser Treatment for Pilonidal Sinus
NCT07023952Recruiting
- Sponsor
- Sancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesi
- Start
- May 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of phenol in pilonidal sinus disease (2 arms), sponsored by Sancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesi. Primary endpoint: Time to Complete Epithelialization at 3 months. Started May 2025; status: recruiting.
02
Drugs
phenol
03
Conditions
pilonidal sinus disease
Beyond the preview
Go deeper on NCT07023952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07023952.